All results

2 results for randomized phase iii double blinded placebo controlled trial aspirin adjuvant therapy

• TN-31 JAKPOT T1D

  A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…

  Ages

  12 Years - 35 Years

  Sexes

  All

• BLOCK-SAH

  BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of…

  Ages

  18 Years - 85 Years

  Sexes

  All